Bard® InLay® Ureteral Stent with NiCore™ Guidewire 776428Recalls & reported problems
C. R. Bard, Inc. · INLAY URETERAL STENT W/NITINOL GUIDEWIRE · Class 2 · Implant
All models of Bard InLay Ureteral Stent with NiCore Guidewire (7)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10801741014212), received between May 10, 2022 and Apr 9, 2026 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Calcified” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Calcified1
- Complete Blockage1
- Inadequacy of Device Shape and/or Size1
- Material Fragmentation1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 9, 2026Inadequacy of Device Shape and/or Size
IT WAS REPORTED BY CRITICAL CARE NURSES IN AN ONLINE SURVEY, AND THEY STATED THAT IN CHARTS 3 AND 4, IN THE ONLINE SURVEY A DR. IN QUESTION: "DO YOU BELIEVE THE BENEFITS OF USING THE INLAY AND INLAY VERSAFIT URETERAL STENTS OUTWEIGH THE POTENTIAL RISKS (I.E. DO THE PROS OUTWEIGH THE CONS)?" SHE OR HE ANSWERED "NO, THE BENEFITS OF USING THIS PRODUCT DO NOT OUTWEIGH THE POTENTIAL RISKS.¿ BECAUSE "WHILE THE PRODUCT OFFERS SEVERAL BENEFITS, THERE ARE SOME POTENTIAL RISKS THAT REQUIRE CONSIDERATION. THE RISKS INCLUDE DATA PRIVACY CONCERNS, LEARNING CURVE FOR NEW USERS, AND POTENTIAL INTEGRATION CHALLENGES WITH EXISTING SYSTEMS. ADDITIONALLY, THERE MAY BE COST BENEFIT CONSIDERATIONS THAT NEED TO BE WEIGHED MORE CAREFULLY IN CERTAIN USE CASES. ", ALSO, IN CHARTS 3 AND 5 IN THE ONLINE SURVEY IN QUESTION: "WAS THE STENT SUCCESSFUL IN RELIEVING URETERAL OBSTRUCTION TO ALLOW FOR URINE " SHE OR HE ANSWERED "NO¿ BECAUSE "TOO SMALL " IN BOTH CHARTS. IN CHART 5 IN THE ONLINE SURVEY A IN QUESTION: "DID THE GUIDEWIRE SUPPORT STENT PLACEMENT PROCEDURE? SHE OR HE ANSWERED "NO¿ BECAUSE "DOESN'T FIT " THE CODE OF PRODUCT IS CHART 3 777400 AND CHART 5 776428.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24832438 ↗MalfunctionApr 15, 2024Calcified; Calcified
CRITICAL CARE NURSES REPORTED IN A PMCF A PHYSICIAN STATED THAT THEIR PATIENT EXPERIENCED STENT ENCRUSTATION AFTER PLACEMENT OF THE DEVICE. THE RESPONDENT INDICATED THEY BELIEVED THE COMPLICATION TO BE A PROCEDURE RELATED COMPLICATION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19106197 ↗MalfunctionMar 29, 2024Complete Blockage; Complete Blockage
CRITICAL CARE PHYSICIAN REPORTED IN A PMCF THAT STENT WAS NOT SUCCESSFUL IN RELIEVING URETERAL OBSTRUCTION TO ALLOW FOR URINE DRAINAGE BECAUSE "THE SPLINT OCCLUDED DURING THE PERIOPERATIVE PERIOD" IN RELATION TO "776428 - INLAYTM URETERAL STENT WITH NICORE NITINOL/NITINOL GUIDEWIRE,4.7 FR.,28CM".
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19007106 ↗MalfunctionMay 10, 2022Material Fragmentation; Material Fragmentation
IT WAS REPORTED THAT THE URETERAL STENT GOT BROKEN IN TWO.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14346049 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page